Cannabis Bioscience International Holdings (CBIH) Payables (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Payables across 4 years of filings, most recently posting $302188.0 for Q1 2026.

• Payables for Q1 2026 came in at $302188.0, up 95.63% year-over-year; the trailing twelve-month figure through Feb 2026 was $302188.0 (up 95.63% YoY), and the FY2025 annual result was $109525.0, down 33.96% from the prior year.
• Payables came in at $302188.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from $159217.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $364788.0 in Q4 2023 to a low of $107660.0 in Q3 2025.
• The 4-year median for Payables is $168355.0 (2024), against an average of $206973.3.
• Across the five-year window, Payables sank 56.75% in 2025 and soared 95.63% in 2026, its largest moves.
• Cannabis Bioscience International Holdings' Payables stood at $364788.0 in 2023, then sank by 53.85% to $168355.0 in 2024, then decreased by 5.43% to $159217.0 in 2025, then surged by 89.8% to $302188.0 in 2026.
• The last three Payables figures came in at $302188.0 (Q1 2026), $159217.0 (Q4 2025), and $107660.0 (Q3 2025), per Business Quant data.